Edition:
United Kingdom

DURECT Corp (DRRX.OQ)

DRRX.OQ on NASDAQ Stock Exchange Global Market

0.56USD
4:51pm BST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.56
Open
$0.56
Day's High
$0.59
Day's Low
$0.56
Volume
14,310
Avg. Vol
108,796
52-wk High
$2.24
52-wk Low
$0.48

About

Durect Corporation is a biopharmaceutical company with research and development programs. The Company's products candidates include DUR-928, oral for metabolic/lipid disorders, and DUR-928, injectable for acute organ injuries. Its other product candidates include POSIMIR (controlled release injection of bupivacaine), REMOXY... (more)

Overall

Beta: 2.03
Market Cap(Mil.): $91.56
Shares Outstanding(Mil.): 162.06
Dividend: --
Yield (%): --

Financials

  DRRX.OQ Industry Sector
P/E (TTM): -- 109.42 62.41
EPS (TTM): -0.16 -- --
ROI: -63.61 7.98 11.81
ROE: -122.07 8.13 12.64

Earnings vs. Estimates